Hurd comments on letter sent to house leadership
'The point that we were trying to make was that, balancing the federal budget should not come at the expense of those that depend on these benefits,' said Hurd.
CD-3 is geographically about half the size of Colorado. About 30% of residents in CD-3 depend on Medicaid.
'We can't and won't support a final reconciliation bill that reduces Medicaid coverage for children and seniors and individuals with disabilities and pregnant women.'
Hurd says the protection of Medicaid is vital, acknowledging reform must be made to ensure it is a strong and long-lasting program for years to come.
'We support targeting reforms that are going to improve Medicaid integrity, reduce proper in-payments and modernize delivery systems.'
The letter states 'Cuts to Medicaid also threaten the viability of hospitals, nursing homes, and safety-net providers nationwide.' Further adding, 'Many hospitals – particularly in rural and underserved areas – rely heavily on Medicaid funding, with some receiving over half their revenue from the program alone.'
The letter continues, saying providers who lose that funding may be at risk of closure and unable to recover, also stating, it would be difficult for all constituents, regardless of healthcare coverage to get the care they need.
Full interview is below.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Early voting starts in Newton County for August election
NEWTON COUNTY, Mo. — The August election is just days away. That means early voting is underway in Newton County. It's a short ballot, a countywide use tax question for all residents of Newton County as well as a city use tax for those living in Neosho. The county clerk's office is open tomorrow, August 2, to cast a ballot; that's from 8:00 a.m. until noon. You can also vote on Monday from 8:00 a.m. until 4:30 p.m. Tuesday is election day, with polls open from 6:00 a.m. to 7:00 p.m. Voting hours summary: Friday, August 2, Newton County Clerk's Office — 8:00 a.m. to 12:00 p.m. Monday, August 5, Newton County Clerk's Office — 8:00 a.m. to 4:30 p.m. Tuesday, August 6, ELECTION DAY — 6:00 a.m. to 7:00 p.m. We'll have the latest election results that night on KODE Action 12 News at 10 and online right here at Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Boston Globe
8 hours ago
- Boston Globe
Researchers forecast what Trump's bill will mean for patients: Debt and delayed care
About 2.5 million people may no longer have a personal doctor. About 1.6 million patients will take on medical debt. The lack of care may cause nearly 22,000 deaths annually. 'There's really no questioning the basic reality that you can't take health care away from 10 million people without causing many preventable deaths,' said Dr. Adam Gaffney, lead researcher on a team that explored the new law's impact. Here's a deeper look at the research and challenges that could develop. Advertisement How the law may affect coverage It will become harder for many people to enroll in Medicaid or individual insurance plans and then stay covered. Medicaid is a state and federally funded program that covers care for people with low incomes. States will have to verify every six months whether someone remains eligible for Medicaid. That could cause coverage lapses for people with incomes that fluctuate or for those who move and miss renewal paperwork. Many also are expected to lose coverage as states require Medicaid recipients to work, volunteer or go to school unless exempted. Related : Enrollment in Medicaid has swelled in recent years. Republicans are cutting back in part to help fund tax breaks and pay for other priorities like border security. They also say they are trying to root out waste and fraud by rightsizing Medicaid for the population it was initially designed to serve — mainly pregnant women, the disabled and children. Advertisement People covered through the Affordable Care Act's individual insurance marketplaces also will see shorter enrollment windows and no more automatic renewals. About the research Gaffney, of Harvard Medical School, and other researchers looked to past studies to measure how many people would experience detrimental effects, like going without prescriptions, from the upcoming changes. Gaffney updated the published analysis, which was originally based on the House version of the bill, at the AP's request. One study in particular was critical for their work: In 2008, Oregon offered a rare opportunity to compare groups of people enrolled in Medicaid with those who were not. The price for a bottle of 60 tablets of Amanda Schlesier's prescription chemotherapy pill, Calquence, printed on a pharmacy statement. Paul Sancya/Associated Press After a four-year period of frozen enrollment due to budget limitations, the state determined it could enroll 10,000 more people in Medicaid. It used a lottery system to make the selection amid high demand. That gave researchers a chance to follow people who got coverage and those who did not, similar to how scientists testing a new drug might compare patients taking it to those given a placebo. 'This is a gold standard research design because it replicates a randomized-controlled trial,' said Christine Eibner, a senior economist at RAND Corp. who was not involved in the study. Related : Applying results from that study and other research to the recent CBO estimate allowed Gaffney and other researchers to estimate specific effects of losing coverage. 'By taking coverage away, we are putting patients in a terrible position,' said Gaffney, a former president of Physicians for a National Health Program. Care could grow complicated Amanda Schlesier went four days without her cancer treatment Calquence this spring and wound up in a local emergency room, delirious with pain. Advertisement The leukemia patient worries about what might happen if she stops treatment again for a longer stretch because she's lost Medicaid. 'God forbid I forget to fill out a page of documentation, and suddenly I lose access to my medication or my doctors or any of the treatment that I've been going through,' the 33-year-old Farmington Hills, Michigan, resident said. People can still receive care when they don't have coverage, but important steps often are delayed, said Dr. Gwen Nichols, chief medical officer of The Leukemia & Lymphoma Society. Patients may be able to visit a doctor, but they would have to line up coverage or help before they can receive expensive chemotherapy. Diagnosis also may be delayed. Meanwhile, the patient's cancer continues to grow. 'It's a ticking time bomb,' Nichols said. Preventive care may lapse The first thing patients often ditch when they lose coverage are screenings designed to catch health problems before they become serious, said Dr. Jen Brull, president of the American Academy of Family Physicians. That could mean patients skip tests for high cholesterol, which can contribute to heart disease, or colonoscopies that detect cancer. Researchers forecast that a half million fewer women will have gotten a mammogram within the past year by 2034. When patients struggle financially and lose coverage, they focus on things like keeping a place to live and food on their table, said Brull, a Fort Collins, Colorado, physician. 'Seeing a doctor because you don't want to get sick feels like a much lower priority,' Brull said. Dennis Heaphy, an advocate with the Massachusetts Disability Policy Consortium, said he would likely be in a nursing home without MassHealth support, during a panel at the Cambridge Health Alliance Revere Care Center on May 27. To his left, Governor Maura Healey and Senator Elizabeth Warren. To his right, Senator Ed Markey. Brett Phelps for The Boston Globe Financial pressure can build Patients start taking financial hits at all ends of care when they lose coverage. They may have to pay up front or start a payment plan before they receive care, said Erin Bradshaw, an executive vice president with the nonprofit Patient Advocate Foundation, which helps people with medical bills. Advertisement Anyone with an outstanding balance will have to pay it before the next appointment. Related : Financial assistance may be available, but patients don't always know about it. Getting help also may take time and require the submission of tax returns, pay stubs or some validation that the patient no longer has coverage. Bradshaw said letters stating that a patient has lost Medicaid sometimes arrive a couple months after the fact. That can contribute to treatment delays or missed medication doses. Some patients also try to avoid financial stress by skipping care. Schlesier said she delayed seeing a doctor when she first felt symptoms of her cancer returning because she had no coverage at the time. Staying on medications If prescriptions are too expensive, patients may simply not get them or split the doses to stretch the medicine. For Thomas Harper, it's a question of priorities. 'Sometimes you have to make a choice, how well do you want to eat this week versus taking your medicine,' he said. The West Monroe, Louisiana, truck driver has around $300 a month in prescriptions as he deals with diabetes and recovers from non-Hodgkin lymphoma, a type of blood cancer. Harper, 57, recently returned to work. That meant he lost Medicaid, which covered more of his prescription costs. He's balancing buying his meds with shopping for healthy food that keeps his blood sugar in check and builds his immune system. 'I'll survive, but I know there's people out there that cannot survive without Medicaid,' he said. AP video journalist Laura Bargfeld contributed to this report. Advertisement
Newsweek
8 hours ago
- Newsweek
Medicare Update: Trump Admin Launching Pilot Program to Cover Ozempic
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Trump administration is preparing a five-year pilot program that would allow Medicare and Medicaid to cover some of the most in-demand weight-loss drugs, a move that could transform obesity treatment for millions of Americans. The plan, which includes medications such as Ozempic, Wegovy, Mounjaro and Zepbound, represents a reversal in federal policy and signals a broader willingness to use public insurance to address the nation's obesity epidemic. Why It Matters The drugs, known as GLP-1 receptor agonists, were initially developed to treat Type 2 diabetes but have become a cultural phenomenon for their ability to suppress appetite and help patients lose as much as 20 percent of their body weight in clinical trials. The pilot builds on a proposal introduced in the final months of the Biden administration but shelved earlier this year when officials under President Donald Trump announced Medicare and Medicaid would not cover weight-loss medications. What To Know According to documents obtained by The Washington Post, the program would allow state Medicaid programs and Medicare Part D plans to voluntarily cover GLP-1 drugs for weight management. The initiative is scheduled to begin in April 2026 for Medicaid and January 2027 for Medicare and will be administered through the Center for Medicare and Medicaid Innovation, which tests new payment models designed to reduce costs and improve care. Chiquita Brooks-LaSure, who led the Centers for Medicare and Medicaid Services under former President Joe Biden, told the Post the experiment would be a "game changer" if it expands access to obesity treatments. "Increased coverage of anti-obesity medications in Medicare and Medicaid was a priority during my tenure because scientists and clinicians increasingly believe obesity is a serious health condition that should be treated accordingly," she said. A pharmacy owner displays an Ozempic package in Pristina, Kosovo, on March 27. A pharmacy owner displays an Ozempic package in Pristina, Kosovo, on March 27. Photo by ARMEND NIMANI/AFP via Getty Images The program faces a major hurdle: price. GLP-1 drugs typically cost from $5,000 to $7,000 a year, raising questions about whether widespread coverage is sustainable. "The short-term cost is still huge," Dr. Cynthia Cox, vice president at KFF (formerly Kaiser Family Foundation), told Newsweek. "$1,000 a month per person is a massive outlay." A KFF analysis found that Ozempic's U.S. list price is $936 a month—more than five times the cost in Japan, where it sells for $169. Wegovy, which contains the same active ingredient, costs roughly $1,349 a month in the U.S., compared to $328 in Germany. At the moment, 13 state Medicaid programs cover GLP-1 drugs for obesity. Medicare limits coverage to patients with related conditions such as diabetes or heart disease. With about 70 million people enrolled in Medicaid and 65 million in Medicare, even partial expansion could affect a significant share of the population. Ethicists warn of the potential economic fallout. "These drugs help over 50 percent of people lose up to 25 percent of their body weight," said Dr. Robert Klitzman, a Columbia University bioethicist, in an interview with Newsweek. "But they cost around $12,000 a year. If two-thirds of Americans needed them, it would bankrupt the health care system." Despite the financial concerns, GLP-1 medications are generating enthusiasm among doctors for their ability to improve multiple health markers beyond weight loss. Clinical trials show they can reduce blood sugar, lower blood pressure and improve cardiovascular outcomes. "Ozempic and other GLP-1 drugs are changing how we approach obesity, both in the doctor's office and for society in general," Dr. Raj Dasgupta, chief medical adviser for Garage Gym Reviews, told Newsweek. "They're helping shift the conversation from 'this is a personal failure' to 'this is a medical condition that deserves real treatment.'" The Congressional Budget Office estimates that adding obesity coverage could cost Medicare $35 billion from 2026 to 2034. What People Are Saying A spokesperson for Novo Nordisk, which manufactures Ozempic and Wegovy, told The Washington Post: "We believe that comprehensive coverage through government and commercial insurance plans is critical to affordable health care and treatment options." Klitzman also said in the interview with Newsweek: "Insurance doesn't always cover it, especially for people who don't have diabetes or heart disease. Initially, the drugs were approved for diabetes-related obesity, but doctors have been prescribing them to people who are just overweight, without those conditions." What Happens Next With more than 100 million U.S. adults classified as obese and 22 million considered severely obese, according to the Centers for Disease Control and Prevention, the program's potential impact is vast. The proposal is not final and could undergo a formal public comment period before implementation.
